Investigators Seek Expanded Use of Checkpoint Inhibitors in RCC
December 5th 2018
In contrast to the wide array of available therapies in the metastatic setting of renal cell carcinoma, in patients with localized disease, the results of trials investigating adjuvant systemic therapy after nephrectomy have so far been underwhelming.